What does the Urolift System device involve?

• The Urolift System is designed to relieve the symptoms of Benign Prostatic Hyperplasia without damaging the tissues.
• The Urolift System device consists of two components, the Urolift delivery device and the Urolift Implant.
• The Urethral Release Prostate surgery (Urolift System) is the only one that solves the symptoms of BPH with outpatient surgery.

One of the main objectives of the development of the Urolift technology is not only to improve the symptoms of Benign Prostatic Hyperplasia, but to do so while preserving the highest possible quality of life for the patient.

The Urolift System, unlike other surgical techniques, does not compromise sexual function and even avoids incontinence. Likewise, Prostate surgery with Urethral Release (Urolift System) allows for outpatient surgery and the complete preservation of all sexual functionality.

The Urolift System is an advanced device created for the Urethral Release Prostate surgery.

This system consists of two components designed to free the urethral duct relieving the symptoms of Benign Prostatic Hyperplasia without the need to damage the prostate or urethral tissue.

The Urolift System is the only one that allows BPH to be solved through outpatient surgery while retaining full sexual function.

The Urolift System consists of two components:

The Urolift application device

The design of the Urolift System delivery device resembles a pistol. Its shape allows it to be inserted transurethrally until it reaches the prostatic urethra, where it will compress the anterolateral prostatic lobe and launch the implant to fix this compression and keep the urethra free. Once this is done, the device is removed and another device is inserted. This is done as many times as necessary to clear the urethra.

The Urolift implant

It is inseparable from the Urolift device. It consists of a tab, which is placed in the area of the capsular prostate tissue, a suture that cannot be reabsorbed by the body, which will pass through the entire prostate lobe, and a urethral clip that will maintain the necessary tension to keep the prostate tissue compressed and thus the urethra free.

The devices are for single use only and both elements, applicator device and implant, are inseparable.

When is the Urolift System indicated?

The Urolift System is indicated to solve the problems caused by Benign Prostatic Hyperplasia, a pathology characterised by the uncontrolled enlargement of the prostate gland due to hormonal factors. This, together with its location in the body being crossed by the urethra, causes a compression of the urethral duct with the consequent problems in urinary evacuation, such as intermittent, difficult or painful urination.

Urolift System urethral release is recommended in prostates smaller than 60 cc (same recommendation as in transurethral resection), with the best results in prostates smaller than 50 cc. The exact size of the prostate before the operation is defined by ultrasound.

Prostate surgery with Urethral Release (Urolift System) is an outpatient procedure and is carried out in 5 separate steps:

1. A standard cystoscope, properly lubricated, is inserted transurethrally (through the penis). This surgical tool provides an entry port for the Urolift System device needed to perform the surgery. Once the cystoscope is in position, the Urolift System device is inserted until it reaches the area of the urethra that crosses the prostate, (the area where the urethra crosses the prostate, just outside the bladder).
2. Once the Urolift System device has reached the area of the urethra that crosses the prostate, it will press the end of the device into one of the anterolateral lobes of the prostate.
3. At this point, the surgeon will activate the device by deploying a needle from the distal end of the device through the previously compressed urethral prostate tissue, until it reaches the capsular prostate tissue (tissue that covers the prostate gland).
4. When the needle reaches the prostate capsule, using the Urolift device, the surgeon unfolds the capsular tongue of the implant. He then retracts the needle again while maintaining compression and tightening the suture.
5. Finally, while maintaining tension on the suture and compression of the prostatic lobe, the device is used to place the implant's urethral clip and cut the excess suture, freeing the urethral duct by keeping the prostatic tissue that caused the obstruction compressed. The device is then removed.

These 5 steps are performed as many times as implants are needed to free the urethral canal. Normally an average of 4 - 5 implants are used.

The treatment is always effective and the results can be seen immediately after the surgery through an endoscope.

Urolift prostate surgery takes approximately 15-20 minutes on average. Moreover, as it is an outpatient procedure, in most cases you can leave the hospital the same day, a few hours after the operation.

The advantages of the Urethral Release Prostate surgery (Urolift System) are numerous, especially in comparison to conventional surgeries. In addition to symptomatic relief, the advantages include the following:

• Immediate and visible results. Once the surgery has been completed, the surgeon can observe the inside of the urethral duct through an endoscope to check that the obstruction has disappeared.
• Outpatient surgery. This operation is performed under sedation, so you will not need to be admitted to hospital and you can leave the hospital the same day and on your own feet.
• Minimally invasive surgical technique. By using a natural orifice for the approach and not removing prostate tissue, the risks and complications are minimised to the maximum.
• No need for a catheter. As no prostate tissue is destroyed, there is usually no need for a catheter after discharge.
• Preservation and improvement of full sexual function:

• 0% of cases of retrograde ejaculation.
• 0% of cases of permanent erectile dysfunction (during the first two weeks after the operation, erection problems may occur, but in all cases they disappear).
• 0% of cases of urinary incontinence.
• 30% improvement in erectile function reported by patients in clinical studies.
• Nearly zero complication and re-intervention rates. Problems disappear within two weeks and results are long lasting.
• Rapid recovery. Symptom relief is immediate, with even more significant improvement within two weeks after surgery.

The Urolift System does not contain any medical substances so an allergic reaction to the device is unlikely.

If you have a clear diagnosis of BPH and are considering treating your prostate problems with the Urolift System, please remember that you can request a free surgical assessment appointment with your Urology specialist by clicking below:

We also offer you our private consultations with renowned specialists in urology, so that they can assess your case and you can decide the best solution to solve the problem. 

You can also request an appointment with the urologist by calling on +34 91 141 33 56 so that our patient service team can explain the steps to follow.

• Alarcón Urology Center. (s.f.). Procedimiento UroLift® para hombres con HPB. Recuperado de https://www.alarconurology.com/espanol/prostata-saludable/tratamiento-hpb-urolift/
• ALCÁNTARA MONTERO, A., & MULLER ARTEAGA, C. (2018, julio). ¿Cuál es la mejor opción de tratamiento quirúrgico en varones con síntomas de la vía urinaria inferior? Recuperado de https://www.medigraphic.com/pdfs/uro/ur-2018/ur184m.pdf
• RadiologyInfo.org. (2020, enero). Hiperplasia prostática benigna (HPB) (el agrandamiento de la próstata). Recuperado de https://www.radiologyinfo.org/sp/pdf/bph.pdf